Vaxess Technologies
Engages in developing biomedical innovations with a focus on improving access to vaccines. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
$135m (Public information from May 2024)
Cambridge Massachusetts (HQ)
Authorizing premium user...